Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc by (c) Zhang et al, 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174837

Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: DNA methylation and gene expression are promising biomarkers of various cancers, including non-small cell lung cancer (NSCLC). Besides the main effects of biomarkers, the progression of complex diseases is also influenced by gene-gene (G×G) interactions. Research question: would screening the functional capacity of biomarkers on the basis of main effects or interactions, using multiomics data, improve the accuracy of cancer prognosis? Study design and methods: biomarker screening and model validation were used to construct and validate a prognostic prediction model. NSCLC prognosis-associated biomarkers were identified on the basis of either their main effects or interactions with two types of omics data. A prognostic score incorporating epigenetic and transcriptional biomarkers, as well as clinical information, was independently validated. Results: twenty-six pairs of biomarkers with G×G interactions and two biomarkers with main effects were significantly associated with NSCLC survival. Compared with a model using clinical information only, the accuracy of the epigenetic and transcriptional biomarker-based prognostic model, measured by area under the receiver operating characteristic curve (AUC), increased by 35.38% (95% CI, 27.09%-42.17%; P = 5.10 × 10-17) and 34.85% (95% CI, 26.33%-41.87%; P = 2.52 × 10-18) for 3- and 5-year survival, respectively, which exhibited a superior predictive ability for NSCLC survival (AUC3 year, 0.88 [95% CI, 0.83-0.93]; and AUC5 year, 0.89 [95% CI, 0.83-0.93]) in an independent Cancer Genome Atlas population. G×G interactions contributed a 65.2% and 91.3% increase in prediction accuracy for 3- and 5-year survival, respectively. Interpretation: the integration of epigenetic and transcriptional biomarkers with main effects and G×G interactions significantly improves the accuracy of prognostic prediction of early-stage NSCLC survival.

Citació

Citació

ZHANG, Ruyang, CHEN, Chao, DONG, Xuesi, SHEN, Sipeng, LAI, Linjing, HE, Jieyu, YOU, Dongfang, LIN, Lijuan, ZHU, Ying, HUANG, Hui, CHEN, Jiajin, WEI, Liangmin, CHEN, Xin, LI, Yi, GUO, Yichen, DUAN, Weiwei, LIU, Liya, SU, Li, SHAFER, Andrea, FLEISCHER, Thomas, BJAANÆS, Maria moksnes, KARLSSON, Anna, PLANCK, Maria, WANG, Rui, STAAF, Johan, HELLAND, Åslaug, ESTELLER, Manel, WEI, Yongyue, CHEN, Feng, CHRISTIANI, David c.. Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects. _Chest_. 2020. Vol. 158, núm. 2, pàgs. 808-819. [consulta: 21 de gener de 2026]. ISSN: 0012-3692. [Disponible a: https://hdl.handle.net/2445/174837]

Exportar metadades

JSON - METS

Compartir registre